📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
0 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
12
PGEN Latest News & AI Sentiment Analysis
0 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 5 ARTICLES
Precigen anticipates PAPZIMEOS gross margin stabilizing in the high 80% to low 90% range as it targets cash flow breakeven by end of 2026 (NASDAQ:PGEN)
Precigen (PGEN) reported exceptional Q2 2026 performance driven by PAPZIMEOS revenue acceleration, which surged 145% year-over-year to...
Precigen, Inc. (PGEN) Q2 2026 Earnings Call Transcript
Precigen (PGEN) released Q2 2026 earnings results via an earnings call transcript, which represents standard quarterly disclosure...
Precigen: Entering The Oncology "Sweet Spot" (NASDAQ:PGEN)
Precigen (PGEN) has received a STRONG BUY rating based on commercial momentum in its oncology portfolio, specifically citing PAPZIMEOS...
Precigen Gains Advantage As PAPZIMEOS Granted Orphan Drug Exclusivity By FDA; Long-Term Data From Clinica
Precigen (PGEN) has secured orphan drug exclusivity designation from the FDA for PAPZIMEOS, a narrowly-focused therapeutic addressing...
Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...
ADIL announced the acquisition of Azora Therapeutics, a strategic move designed to expand its clinical pipeline and enhance its...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice